ClinicalTrials.gov
public full text
Public Domain
First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression
The aim of this randomized controlled trial is to restore immune function by selectively removing three mediators largely contributing to sepsis-induced immunosuppression from extracorporeal circulation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evolution of Sepsis Management in the Emergency Department: From Early Goal-Directed Therapy to Personalized Resuscitation.#461504
- Sepsis as an Immune Continuum: Cytokine Storm to Lymphopenia and PICS#191328
- Immune-regulating complex orchestrates protection against sepsis#174198
- Effect of APC and Epo on the Inflammatory Response During Sepsis#1337654
- Exercise in Critically Ill Patients With Sepsis#830959
Record · ID 1307048
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive